Lipopen (Ezetimibe, Rosuvastatin)

Lipopen is used to treat lipid disorders by lowering elevated cholesterol and triglyceride levels.

• Hypercholesterolemia: reduces LDL‑cholesterol and total cholesterol levels.
• Mixed dyslipidemia: improves the overall lipid profile including LDL, HDL and triglycerides.
• Familial hypercholesterolemia: provides additional LDL‑cholesterol reduction when diet and lifestyle alone are insufficient.

• Ezetimibe selectively blocks the Niemann‑Pick C1‑like 1 (NPC1L1) transporter in the intestinal brush‑border, preventing dietary and biliary cholesterol absorption. Rosuvastatin competitively inhibits HMG‑CoA reductase, the key enzyme in hepatic cholesterol synthesis, leading to up‑regulation of LDL receptors and increased clearance of circulating LDL‑cholesterol. The complementary actions result in a synergistic reduction of plasma cholesterol.

Lipopen may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects

• Headache: mild to moderate intensity.
• Myalgia: muscle aches without weakness.
• Abdominal discomfort: including dyspepsia or flatulence.
• Diarrhea: loose stools.
• Elevated liver enzymes: mild transaminase increase.

Serious or Rare Side Effects

• Rhabdomyolysis: severe muscle breakdown with possible renal impairment.
• Hepatotoxicity: marked elevation of liver enzymes or jaundice.
• Severe allergic reactions: rash, angioedema or anaphylaxis.
• Acute pancreatitis: sudden abdominal pain with elevated enzymes.
• Interstitial lung disease: rare pulmonary inflammation.

Before prescribing Lipopen, clinicians should consider several precautionary measures to ensure patient safety.

• Liver function assessment: obtain baseline transaminases and monitor periodically.
• Renal impairment: adjust therapy in patients with severe renal dysfunction.
• Drug interactions: review concomitant medications that affect statin metabolism.
• Pregnancy and lactation: avoid use unless benefits outweigh potential risks.
• Myopathy risk: assess for muscle symptoms, especially when combined with fibrates.
• Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Lipopen can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin): increase rosuvastatin exposure.
• Cyclosporine: markedly raises rosuvastatin plasma levels.
• Gemfibrozil: heightens risk of myopathy and rhabdomyolysis.
• Antacids containing aluminum or magnesium: may reduce ezetimibe absorption.

Moderate Interactions (Monitor Closely)

• Anticoagulants (warfarin): may require INR monitoring.
• Niacin: can increase risk of liver enzyme elevations.
• Digoxin: rosuvastatin may raise digoxin concentrations.
• St. John’s wort: may modestly reduce rosuvastatin levels.